Keyphrases
Heart Failure
100%
Atrial Fibrillation
49%
Pulmonary Embolism
39%
Nationwide Registry
37%
Myocardial Infarction
37%
High Risk
37%
Heart Failure Risk
35%
Thromboembolic Risk
35%
Copenhagen
35%
Risk Study
35%
Cancer-associated Thrombosis
35%
Patients with Cancer
29%
Natriuretic Peptides
27%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
25%
Low Molecular Weight Heparin
25%
Venous Thromboembolism
24%
Renal Function
24%
Randomized Clinical Trial
23%
Left Atrial Appendage
23%
Cardiotoxicity
23%
COVID-19
23%
National Cohort Study
23%
Percutaneous Left Atrial Appendage Occlusion
23%
Women with Breast Cancer
23%
Cardiovascular Disease in Women
23%
Cardiology Practice
23%
Direct Oral Anticoagulants
23%
Mineralocorticoid Receptor Antagonists
21%
Plasma Concentration
20%
Echocardiography
20%
Cardiovascular Disease
20%
Reduced Ejection Fraction
19%
Guideline-directed Medical Therapy
17%
Confidence Interval
17%
Heart Disease Diagnosis
17%
Chronic Kidney Disease
17%
Guideline Recommendations
16%
Atrial Natriuretic Peptide
16%
Diabetes
16%
Clinical Practice
16%
Oral Anticoagulant Therapy
16%
Left Ventricular Ejection Fraction
16%
Left Ventricular Systolic Function
15%
Registry Study
15%
Infection-related
15%
Left Ventricular Strain
14%
Breast Cancer
13%
Beta-blockers
13%
Angiotensin Receptor-neprilysin Inhibitor
13%
Apixaban
13%
Medicine and Dentistry
Heart Failure
46%
Atrial Fibrillation
46%
Malignant Neoplasm
26%
Thromboembolism
25%
Venous Thromboembolism
25%
Pulmonary Embolism
25%
Infection
23%
Cardiovascular Disease in Women
23%
Breast Cancer
23%
Cardiology
23%
Cardiovascular Disease
20%
Antithrombotic
20%
Mineralocorticoid Antagonist
19%
Systolic Function
18%
Thrombosis
17%
Echocardiography
16%
Apoplexy
15%
Prevalence
15%
Ejection Fraction
15%
Anticoagulant Therapy
14%
Chronic Kidney Disease
14%
Combination Therapy
14%
Heart Function
12%
Heart Failure with Reduced Ejection Fraction
12%
Symptom
12%
Systolic Dysfunction
11%
Ischemia
11%
Oncologist
11%
Sarcoma
11%
Observational Study
11%
Aquagenic Pruritus
11%
Cerebral Hemorrhage
11%
Androgen
11%
Attitude
11%
Patient with Type 2 Diabetes
11%
COVID-19
11%
Gangrene
11%
Concurrent Infection
11%
Phlebothrombosis
11%
Cardiotoxicity
11%
Drug Megadose
11%
Coronavirinae
11%
Heart Valve Surgery
11%
Left Bundle Branch Block
11%
Microthrombus
11%
Doxorubicin
11%
Population Risk
11%
Randomized Clinical Trial
11%
Virus Infection
11%
Selective Serotonin Reuptake Inhibitor
11%
Pharmacology, Toxicology and Pharmaceutical Science
Atrial Fibrillation
64%
Heart Failure
53%
Thromboembolism
37%
Venous Thromboembolism
37%
Anticoagulant Agent
36%
Heart Infarction
25%
Lung Embolism
25%
Infection
24%
Natriuretic Factor
23%
Cardiotoxicity
23%
Atrial Natriuretic Factor
19%
Malignant Neoplasm
18%
Chronic Kidney Failure
16%
Bleeding
16%
Low Molecular Weight Heparin
15%
Cardiovascular Disease
14%
Creatinine
14%
Cohort Study
13%
Combination Therapy
12%
Albuminuria
12%
Heart Failure with Reduced Ejection Fraction
12%
Breast Cancer
12%
Systolic Dysfunction
11%
Sarcoma
11%
Capecitabine
11%
Fluorouracil
11%
Androgen
11%
Colorectal Cancer
11%
Recurrent Disease
11%
Systolic Heart Failure
11%
Direct Oral Anticoagulant
11%
Concurrent Infection
11%
Coronavirinae
11%
Doxorubicin
11%
Virus Infection
11%
Galectin 3
11%
Spironolactone
11%
Non Insulin Dependent Diabetes Mellitus
11%
Kidney Disease
11%
Anticoagulation Therapy
11%
Antivitamin K
9%
Brain Natriuretic Peptide
8%
Sodium Glucose Cotransporter 2 Inhibitor
8%
Apixaban
6%
Copeptin
6%
Prevalence
6%
Ischemic Heart Disease
6%
Mineralocorticoid Antagonist
5%
Drug-Drug Interaction
5%
Angiotensin Receptor
5%
